Case | HBS Case Collection | April 2012 (Revised May 2012)

Merck: Operating Science-Based Business

by Ananth Raman, Inga Maurer and William Schmidt

Abstract

Merck is known for its commitment to investing in basic R&D. Are Merck's long-term investments justifiable when the firm faces extreme earnings pressure?

Keywords: Science-Based Business; Management; Research and Development; Business and Shareholder Relations; Operations; Pharmaceutical Industry; United States;

Citation:

Raman, Ananth, Inga Maurer, and William Schmidt. "Merck: Operating Science-Based Business." Harvard Business School Case 612-082, April 2012. (Revised May 2012.)